2011
Factors affecting lymphovascular invasion in node-positive breast cancer patients.
Cornwell L, McMasters K, Chagpar A. Factors affecting lymphovascular invasion in node-positive breast cancer patients. Journal Of Clinical Oncology 2011, 29: 24-24. DOI: 10.1200/jco.2011.29.27_suppl.24.Peer-Reviewed Original ResearchBreast cancer patientsLVI positivityCancer patientsExtracapsular extensionLarge tumorsNode-positive breast cancer patientsPositive lymph nodesProportion of patientsCohort of patientsPoor prognostic factorProspective multicenter studySynoptic pathology reportsBreast cancer tumorsBreast practicePositive nodesLarge metastasesLymphovascular invasionPatient agePrognostic factorsSurgery typeClinicopathologic factorsLymph nodesMulticenter studyVascular invasionPathology reports
2009
Prediction of Thromboembolic Events in Women with Hormone Receptor-Positive Breast Cancer Receiving SERMS
Lewis J, Chagpar A, McMasters K, Edwards M. Prediction of Thromboembolic Events in Women with Hormone Receptor-Positive Breast Cancer Receiving SERMS. Journal Of Surgical Research 2009 DOI: 10.1016/j.jss.2009.03.089.Peer-Reviewed Original ResearchSelective estrogen receptor modulatorsHormone receptor-positive breast cancerReceptor-positive breast cancerDeep venous thrombosisThromboembolic eventsPulmonary emboliBreast cancerTamoxifen Adjuvant trialTransient ischemic attackOnly independent factorAcute myocardial infarctionEstrogen receptor modulatorsAdjuvant trialsIschemic attackPositive nodesThromboembolic riskLymphovascular invasionCerebrovascular accidentClinicopathologic factorsVenous thrombosisTreatment armsMyocardial infarctionUnivariate analysisReceptor modulatorsResults NinetyFactors influencing the decision to add chemotherapy to adjuvant hormonal therapy in women with hormone receptor-positive breast cancer.
Chagpar A, Lewis J, McMasters K, Edwards M. Factors influencing the decision to add chemotherapy to adjuvant hormonal therapy in women with hormone receptor-positive breast cancer. Cancer Research 2009, 69: 4105. DOI: 10.1158/0008-5472.sabcs-4105.Peer-Reviewed Original ResearchAddition of chemotherapyHormone receptor-positive breast cancerReceptor-positive breast cancerAbsolute survival benefitAdjuvant hormonal therapyOverall survival benefitHormonal therapySurvival benefitOverall survivalAdjuvant chemotherapyClinicopathologic factorsAbsolute benefitBreast cancerHormone receptor-positive patientsReceptor-positive patientsTamoxifen Adjuvant trialMedian patient ageMedian tumor sizeMajority of patientsYears of ageCohort of interestAdjuvant trialsLymphovascular invasionPatient agePositive disease